NCT07061080
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07061080
Title Refractory Advanced diGestive Neuroendocrine Carcinomas Treated With tARlatamab (RAGNAR)
Acronym RAGNAR
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Grupo Espanol de Tumores Neuroendocrinos
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA | ESP


No variant requirements are available.